Nirmatrelvir Cuts Risk for Post-COVID-19 Condition
MONDAY, March 27, 2023 (HealthDay News) -- Treatment with nirmatrelvir during the acute phase of COVID-19 may reduce the risk for postacute adverse health outcomes, according to a study…
Browsing Tag
Nirmatrelvir
Heteros COVID-19 Oral Medication Nirmacom Receives WHO Prequalification
Nirmacom by Hetero will comprise nirmatrelvir 150 mg (2 tablets) and ritonavir 100mg (1 tablet). A patient would pay roughly $4,900 for the full course, according to an industry source, who…
Nirmatrelvir Plus Ritonavir Reduces Risks for COVID-19 in Seniors
Elana Gotkine
MONDAY, Dec. 12, 2022 (HealthDay News) -- Nirmatrelvir plus ritonavir reduces the risk for hospitalization or death after an outpatient…